Diagnosis of hydatidiform moles using p57 immunohistochemistry and chromogenic insitu hybridization: A retrospective study
Authors:
Open Access
- 10 November 2024
- journal article
- research article
- Published by Knowledge E DMCC in International Journal of Reproductive BioMedicine (IJRM)
- Vol. 22 (9) , 727-738
Abstract
Background: Chromogenic in situ hybridization (CISH) and immunohistochemistry analysis for p57 are ancillary studies discriminating partial hydatidiform mole (PHM), complete hydatidiform mole (CHM), and non-molar hydropic abortion (HA). Objective: It aimed to study CISH with a probe to chromosome 17 (CISH17) and chromosome 2 (CISH2) discriminating chromosomal ploidy of PHM, CHM, and HA; in addition, their surrogacy value in the evaluation of triploid and diploid in product of conception specimens (POCs) was evaluated. Materials and Methods: 44 statistically significant POCs were selected retrospectively. The Kappa agreement coefficients, sensitivity, specificity, and accuracy with 95% confidence interval (95% CI) were reported. Results: PHM, CHM, and HA were diagnosed to be 23, 17, and 3 cases based on both CISH2 and CISH17 resulting in their complete discrimination between PHM and HA (23 vs. 3). The Kappa agreement coefficient was 95.4% (p < 0.001) when diagnosing the PHM (23), CHM (20), and HA (1). In addition, the accuracy, sensitivity, and specificity were 95.26% (95% CI: 84.25–99.38), 100% (95% CI: 85.18–100), and 95% (95% CI: 76.18–99.88), respectively. The power analysis on CISH2 and CISH17 tests discriminating between triploid and diploid in POCs was estimated to be 100%. Conclusion: Based on the current finding, CISH2 and CISH17 enjoyed perfect agreement in diagnosing chromosomal ploidy; in addition, their absolute power discriminating between triploid and diploid revealed that they could be used as surrogate markers for ploidy. Prospective studies on fresh specimens are suggested comparing the CISH method’s accuracy with flow cytometry karyotyping and fluorescence in situ hybridization. Key words: Hydatidiform mole, CISH protein, Human, Pathology, Clinical.Keywords
This publication has 21 references indexed in Scilit:
- Prevalence of Partial Hydatidiform Mole in Products of Conception From Gestations With Fetal Triploidy Merits Reflex Genotype Testing Independent of the Morphologic Appearance of the Chorionic VilliAmerican Journal of Surgical Pathology, 2020
- p57 in Hydatidiform Moles: Evaluation of Antibodies and Expression in Various Cell TypesApplied Immunohistochemistry & Molecular Morphology, 2019
- Hydatidiform Moles: Ancillary Techniques to Refine DiagnosisArchives of Pathology & Laboratory Medicine, 2018
- Temporal trends in incidence and outcome of hydatidiform mole: a retrospective cohort studyActa Oncologica, 2018
- Morphological Features and Immunohistochemical Expression of p57Kip2 in Early Molar Pregnancies and Their Relations to the Progression to Persistent Trophoblastic DiseaseJournal of Pathology and Translational Medicine, 2017
- Histological comparison of partial hydatidiform mole and trisomy gestation specimensPathology, 2016
- Application of HER2 CISH pharmDX for DNA Ploidy DeterminationApplied Immunohistochemistry & Molecular Morphology, 2016
- Utilization of Chromogenic In Situ Hybridization to Assess Ploidy in the Diagnosis of Hydatidiform MoleAmerican Journal of Clinical Pathology, 2016
- Chromogenic in situ hybridization compared with other approaches to evaluate HER2/neu status in breast carcinomasBrazilian Journal of Medical and Biological Research, 2013
- Analysis of gestational trophoblastic disease by genotyping and chromosome in situ hybridizationLaboratory Investigation, 2004